These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 418458)

  • 41. Antinociceptive effects of lanthanum and cerium in nontolerant and morphine tolerant-dependent animals.
    Harris RA; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Feb; 196(2):288-97. PubMed ID: 176345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1984 Jun; 102(1):13-22. PubMed ID: 6148243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperalgesic effects of divalent cations and antinociceptive effects of a calcium chelator in naive and morphine-dependent mice.
    Schmidt WK; Way EL
    J Pharmacol Exp Ther; 1980 Jan; 212(1):22-7. PubMed ID: 6766187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration.
    Bhargava HN
    Psychopharmacology (Berl); 1980; 68(2):185-9. PubMed ID: 6776564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in locomotor activity and naloxone-induced jumping in mice produced by WIN 35, 197-2 (ethylketazocine) and morphine.
    Tepper P; Woods JH
    Psychopharmacology (Berl); 1978 Jul; 58(2):125-9. PubMed ID: 98778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice.
    Bhargava HN
    Pharmacol Biochem Behav; 1980 May; 12(5):645-9. PubMed ID: 7190300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of acute and chronic morphine dependence in male and female mice.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A
    Pharmacol Biochem Behav; 2001 Sep; 70(1):149-56. PubMed ID: 11566152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of agonist-antagonist interaction on the development of tolerance and dependence.
    Cochin J; Mushlin BE
    Ann N Y Acad Sci; 1976; 281():244-51. PubMed ID: 190935
    [No Abstract]   [Full Text] [Related]  

  • 55. Conditioned behavioral and physiological changes associated with injections of a narcotic antagonist in morphine-dependent monkeys.
    Goldberg SR
    Pavlov J Biol Sci; 1976; 11(4):203-21. PubMed ID: 825815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for the dissociation of morphine analgesia, tolerance and dependence.
    Kaneto H; Yamazaki A; Kihara T
    J Pharm Pharmacol; 1985 Jul; 37(7):507-8. PubMed ID: 2863361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
    Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
    Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice.
    Ozdoğan UK; Lähdesmäki J; Scheinin M
    Eur J Pharmacol; 2003 Jan; 460(2-3):127-34. PubMed ID: 12559372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.